Camera Based System to Monitor Patient Movement During Radiation Treatment

Set up and Monitoring of Patients Receiving Proton Radiation Clinical Trial

— DS02  

Official title:

Improving Safety and Accuracy of Proton Therapy by Use of Camera-Based Patient Localization System

Clinical Trial Details — Status: Terminated

Administrative data

• NCT number: NCT01971866
• Other study ID #: UFPTI 1215-DS02
• Status: Terminated
• Phase: N/A
• First received: October 17, 2013
• Last updated: January 26, 2016
• Start date: October 2013
• Est. completion date: July 2015

Study information

• Verified date: January 2016
• Source: University of Florida
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Institutional Review Board
• Study type: Observational

Clinical Trial Summary

This study aims to investigate the advantages of using AlignRT, a commercially available, FDA approved camera-based imaging system for proton therapy patients prior to and during their radiation treatment delivery.

Recruitment information / eligibility

• Status: Terminated
• Enrollment: 1
• Est. completion date: July 2015
• Est. primary completion date: July 2015
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

Patients with tumors of the brain, head and neck, thorax, upper abdomen, posterior spine/sacrum and extremities

Study Design

Observational Model: Case-Only, Time Perspective: Prospective

Related Conditions & MeSH terms

• Set up and Monitoring of Patients Receiving Proton Radiation

Locations

Country	Name	City	State
United States	University of Florida Proton Therapy Institute	Jacksonville	Florida

Sponsors (1)

Lead Sponsor	Collaborator
University of Florida

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Paired difference between image accuracy plan data from the AlignRT system compared to the current x-ray based imaging system.	Enrollment and analysis will be restricted to adult patients with tumors of the brain, head and neck region, thorax, upper abdomen, or posterior spine/sacrum. Primary outcome will be analyzed by paired t-test.	3 months	Yes